Domini International Opportunities Inv RISEX

Medalist Rating as of | See Domini Investment Hub
  • NAV / 1-Day Return 11.37  /  +0.35 %
  • Total Assets 24.5 Mil
  • Adj. Expense Ratio
    1.400%
  • Expense Ratio 1.400%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 0.87%
  • Turnover 18%

USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:12 PM GMT+0

Morningstar’s Analysis RISEX

Will RISEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Domini International Opportunities Inv's Average Process Pillar and People Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RISEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 29.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

5.88 1.4 Mil
Healthcare

ASML Holding NV

4.85 1.1 Mil
Technology

AstraZeneca PLC

2.83 668,910
Healthcare

Novartis AG Registered Shares

2.79 658,953
Healthcare

Toyota Motor Corp

2.69 633,928
Consumer Cyclical

SAP SE

2.52 593,989
Technology

Linde PLC

2.51 593,271
Basic Materials

Siemens AG

1.79 423,063
Industrials

Commonwealth Bank of Australia

1.72 405,598
Financial Services

Unilever PLC

1.61 380,424
Consumer Defensive

Sponsor Center